The key finding of our study was that patients with full recovery after therapy showed a significantly more pronounced low baseline DNA methylation of the LEP gene with an increase of more than 8% at the 12-months follow-up, while patients with a partial syndrome AN after therapy started with a higher methylation which increased less. Here, LEP is linked to Down syndrome.